Visualization of choline-containing phospholipids in cells and in vivo is made possible by the metabolic incorporation of a choline analog with an alkyne handle for click chemistry–based labeling.

Analysis by Mount Sinai researcher from First-of-its kind global trial could lead to future therapies to prevent deadly ...

A phase 2 trial shows that olpasiran, an RNA-based therapy, reduces lipoprotein(a) [Lp(a)] levels by more than 95% in ...

Disorders in endogenous lipid metabolism have been associated with ... amyloid-β and tau, and phospholipids, sphingolipids, cholesterol and oxysterols as representatives of membrane lipids ...

Anglia Ruskin University and Arctic Bioscience are researching herring roe omega-3 to uncover its benefits for exercise ...

The RNA inhibitor olpasiran significantly reduces a type of "bad cholesterol" that's associated with a high risk of cardiovascular events, according to results from an analysis by a Mount Sinai ...